Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07201831 · ClinicalTrials.gov registry record
A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 1,330
- Enrollment target
NCT07201831 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 1,330 participants.
The verdict
NCT07201831 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 1,330 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information for scientific research and to better understand awareness and to understand overall risk awareness, diagnoses and treatment related to liver related diseases. The study aims to collect valid responses through online questionnaires from the participants. This study is a survey-based study without collection of laboratory data. It will take the participant 25 minutes to complete the survey. The study is not related to any specific treatment options or pharmaceutical product.
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,330 participants |
| Start Date | 2025-10-02 |
| Est. Completion | 2026-01-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07201831
The ClinicalTrials.gov registry entry for NCT07201831 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT07201831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07201831 about?
NCT07201831 is a clinical study titled "A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population". The purpose of this study is to collect information for scientific research and to better understand awareness and to understand overall risk awareness, diagnoses and treatment related to liver related diseases. The study aims to collect valid responses through online questionnaires from the partici...
What is the current status of trial NCT07201831?
This trial is currently completed. The enrollment target is 1,330 participants. The study started on 2025-10-02. Estimated completion is 2026-01-17.
What interventions are being tested in trial NCT07201831?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT07201831?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.